Suppliers / Fresenius Kabi Deutschland

Fresenius Kabi Deutschland

Germany 339 employees Updated 9 July 2026

Fresenius Kabi Deutschland is a finished-dose manufacturer based in Germany. It appears in 157 regulatory filings across 3 regulators, without an active US DMF or CEP on file. Its filings concentrate with EMA, DAV (Vietnam) and BFARM (DE). Its GMP standing is certified by ZLG (DE) and EMA. Its most recent recorded inspection, by US FDA, closed on 19 October 2022 as VAI.

0
active US DMFs
0
valid CEPs
4
registered plants 1 with an FDA FEI number
157
filings across 3 regulators
These figures were checked against the regulators' own files on 25 July 2026
Plants
1 of 1 confirmed
Inspections
3 of 3 confirmed
EU GMP
1 of 1 confirmed
Sources: FDA Establishment Registration, read 4 May 2026. FDA drug inspection classifications, read 4 May 2026. EudraGMDP (MIA + third-country GMP certs), read 4 May 2026.

Inspection history

  • 19 October 2022 VAI US FDA
  • 11 April 2018 VAI US FDA
  • 26 September 2014 VAI US FDA

NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.

Registered plants

Site FDA FEI
FRIEDBERG, Germany Not on file
Hesse, Germany Not on file
Friedberg (Hessen), Germany Not on file
Germany, Germany 3002851530

Filings and GMP by regulator

Regulator Filings GMP certificates
EMA 133 3
DAV (Vietnam) 20 None
BFARM (DE) 4 None
ZLG (DE) None 12

Comparing suppliers?

Choose your molecules and target markets. Fresenius Kabi Deutschland comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Open risk flags

  • The most recent inspection outcome was VAI, on 19 October 2022.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability
EudraGMDP and national regulators
GMP certificates